Insight Molecular Diagnostics Inc. Finance Lease, Liability, Undiscounted Excess Amount
Insight Molecular Diagnostics Inc. (IMDX) had Finance Lease, Liability, Undiscounted Excess Amount of $38.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Notes › Leases
us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount · last filed 2026-08-10
- 2026-06-30: Finance Lease, Liability, Undiscounted Excess Amount $38.00K.
- 2026-03-31: Finance Lease, Liability, Undiscounted Excess Amount $53.00K.
- 2025-12-31: Finance Lease, Liability, Undiscounted Excess Amount $71.00K.
- 2025-09-30: Finance Lease, Liability, Undiscounted Excess Amount $93.00K.
| Period end | Finance Lease, Liability, Undiscounted Excess Amount |
|---|---|
| 2026-06-30 | $38.00K 10-Q · filed 2026-08-10 |
| 2026-03-31 | $53.00K 10-Q · filed 2026-05-13 |
| 2025-12-31 | $71.00K 10-K · filed 2026-03-26 |
| 2025-09-30 | $93.00K 10-Q · filed 2025-11-10 |
| 2025-06-30 | $103.00K 10-Q · filed 2025-08-11 |
| 2025-03-31 | $97.00K 10-Q · filed 2025-05-12 |
| 2024-12-31 | $111.00K 10-K · filed 2025-03-24 |
| 2024-09-30 | $136.00K 10-Q · filed 2024-11-12 |
| 2024-06-30 | $72.00K 10-Q · filed 2024-08-08 |
| 2023-09-30 | $1.00K 10-Q · filed 2023-11-09 |
| 2023-06-30 | $2.00K 10-Q · filed 2023-08-10 |
| 2023-03-31 | $4.00K 10-Q · filed 2023-05-15 |
| 2022-12-31 | $7.00K 10-K · filed 2023-04-12 |
| 2022-09-30 | $11.00K 10-Q · filed 2022-11-10 |
| 2019-09-30 | $19.00K 10-Q · filed 2019-11-14 |
| 2019-06-30 | $25.00K 10-Q · filed 2019-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |